R1487 is an orally bioavailable and highly selective p38α mitogen-activated protein kinase inhibitor.
靶点:
p38 MAPK
参考文献:
1. Dunford E C , Herbst E A , Jeoung N H , et al. PDH activation during in vitro muscle contractions in PDH kinase 2 knockout mice: Effect of PDH kinase 1 compensation[J]. American Journal of Physiology Regulatory Integrative & Comparative Physiology, 2011, 300(6):R1487.